Editas Medicine
(NASDAQ:EDIT)
$14.34
-0.21[-1.44%]
At close: Jul 6
$14.25
-0.0900[-0.63%]
After Hours: 5:48PM EDT
Day High/Low13.95 - 15.07
52 Week High/Low9.59 - 73.03
Open / Close14.42 / 14.34
Float / Outstanding61.2M / 68.6M
Vol / Avg.1.9M / 1.7M
Mkt Cap984.3M
P/E-
50d Avg. Price12.08
Div / Yield-
Payout Ratio-
EPS-0.74
Total Float61.2M

Editas Medicine (NASDAQ:EDIT), Quotes and News Summary

Editas Medicine (NASDAQ: EDIT)

Day High/Low13.95 - 15.07
52 Week High/Low9.59 - 73.03
Open / Close14.42 / 14.34
Float / Outstanding61.2M / 68.6M
Vol / Avg.1.9M / 1.7M
Mkt Cap984.3M
P/E-
50d Avg. Price12.08
Div / Yield-
Payout Ratio-
EPS-0.74
Total Float61.2M
Sector: Health Care.Industry: Biotechnology
Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-0.790-0.740 0.0500
REV3.850M6.771M2.921M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Editas Medicine Questions & Answers

Q
How do I buy Editas Medicine (EDIT) stock?
A

You can purchase shares of Editas Medicine (NASDAQ: EDIT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Editas Medicine's (EDIT) competitors?
Q
What is the target price for Editas Medicine (EDIT) stock?
A

The latest price target for Editas Medicine (NASDAQ: EDIT) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 8.00 expecting EDIT to fall to within 12 months (a possible -44.21% downside). 12 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Editas Medicine (EDIT)?
A

The stock price for Editas Medicine (NASDAQ: EDIT) is $14.34 last updated July 6, 2022, 8:00 PM UTC.

Q
Does Editas Medicine (EDIT) pay a dividend?
A

There are no upcoming dividends for Editas Medicine.

Q
When is Editas Medicine (NASDAQ:EDIT) reporting earnings?
A

Editas Medicine’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is Editas Medicine (EDIT) going to split?
A

There is no upcoming split for Editas Medicine.

Q
What sector and industry does Editas Medicine (EDIT) operate in?
A

Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.